查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1959327

经肠营养原料市场机会、成长要素、产业趋势分析及预测（2026-2035年）

Enteral Nutrition Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 209 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球经肠营养成分市场价值为 43.1 亿美元，预计到 2035 年将达到 85.8 亿美元，年复合成长率为 7.3%。

肠内营养成分市场-IMG1

市场扩张的驱动力在于慢性病盛行率上升和临床营养解决方案需求成长，进而推动了对长期营养支持的需求。医疗机构越来越多地选择经肠营养经肠营养而非其他营养方式，因为肠内营养具有成本效益高、併发症风险低、且能改善患者復健效果等优点。这种持续的转变直接推动了对蛋白质、碳水化合物、脂类、维生素和矿物质等关键营养素的需求。人口结构变化也发挥重要作用，全球老年人口的不断增长需要专业的营养管理。医疗机构和养老院老年护理服务的扩展促使生产商开发易于消化且营养优化的成分。同时，成分加工和配方技术的持续创新正在提高产品的功效、耐受性和临床适用性，从而进一步促进市场成长。

市场范围
开始年份 2025
预测年份 2026-2035
起始金额 43.1亿美元
预测金额 85.8亿美元
复合年增长率 7.3%

预计到2025年，碳水化合物原料市场规模将达到13.6亿美元，并在2026年至2035年间以6.7%的复合年增长率成长。各类原料的整体成长受到配方要求日益复杂和临床营养标准不断演进的推动。蛋白质越来越多地被用于支持肌肉的维持和恢復，而碳水化合物原料则不断精炼，以提供持续的能量供应并改善代谢反应。脂质和脂肪越来越多地被製成特殊结构，以提高吸收率和消化率。原料功能的扩展正在拓宽其应用范围，从标准营养製剂到针对特定疾病的营养製剂。

2025年，重症监护/ 加护病房（ICU）领域的市场规模将达到15.6亿美元，市占率为36.3%。预计到2035年，年复合成长率（CAGR）将达到6.6%。临床营养管理实践的改变导致急性护理环境中经肠营养的早期启动，从而增加了对支持代谢稳定和器官功能的成分的需求。此外，营养支持越来越融入疾病管理流程，导致配方更加复杂，成分用量也随之增加。

预计到2025年，北美经肠营养原料市场规模将达到17.9亿美元，并在整个预测期内保持强劲成长。该地区受益于先进的医疗保健基础设施、完善的报销系统以及医院和居家医疗机构中临床营养的广泛应用。美国由于人口老化和长期健康问题高发，在该市场中扮演核心角色，临床指南也日益强调使用特定蛋白质、脂质、纤维和微量营养素进行有针对性的营养干预的重要性。

目录

第一章：调查方法

第二章执行摘要

第三章业界考察

  • 生态系分析
    • 供应商情况
    • 利润率
    • 每个阶段增加的价值
    • 影响价值链的因素
    • 中断
  • 影响产业的因素
    • 促进因素
    • 产业潜在风险与挑战
    • 市场机会
  • 成长潜力分析
  • 监理情势
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特的分析
  • PESTEL 分析
  • 价格趋势
    • 按地区
    • 副产品
  • 未来市场趋势
  • 科技与创新趋势
    • 当前技术趋势
    • 新兴技术
  • 专利状态
  • 贸易统计（註：仅提供主要国家的贸易统计）
    • 主要进口国
    • 主要出口国
  • 永续性和环境方面
    • 永续倡议
    • 减少废弃物策略
    • 生产中的能源效率
    • 具有环保意识的倡议
  • 碳足迹考量

第四章 竞争情势

  • 介绍
  • 企业市占率分析
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • 中东和非洲
  • 企业矩阵分析
  • 主要市场公司的竞争分析
  • 竞争定位矩阵
  • 主要进展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 业务拓展计划

第五章 市场估算与预测：依原料类型划分，2022-2035年

  • 蛋白质原料
    • 总蛋白
    • 水解蛋白质/胜肽
    • 游离胺基酸
    • 功能性胺基酸
  • 碳水化合物原料
    • 麦芽糊精
    • 玉米糖浆固态/葡萄糖
    • 复合碳水化合物
    • 单醣
  • 脂类/脂肪原料
    • 长链三酸甘油酯（LCTs）
    • 中链三酸甘油酯（MCT）
    • Omega-3脂肪酸
    • 单元不饱和脂肪酸（MUFA）
    • 结构化脂质和混合乳化剂
  • 膳食纤维成分
    • 水溶性膳食纤维
    • 不溶性膳食纤维
    • 抗淀粉
    • 益生元纤维
  • 微量营养素来源
    • 维他命
    • 矿物
    • 电解质
    • 微量元素
  • 功能性和增强免疫力的成分
    • 核苷酸
    • 益生菌
    • 抗氧化剂
    • 生物活性胜肽
  • 其他的

第六章 市场估计与预测：依应用领域划分，2022-2035年

  • 重症监护/加护病房（ICU）
  • 肿瘤学/癌症
  • 消化系统疾病
  • 神经系统疾病
  • 代谢性疾病
  • 其他的

第七章 市场估计与预测：依地区划分，2022-2035年

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

第八章：公司简介

  • Abbott
  • Nutricia（Danone）
  • Nestle Health Science
  • Fresenius Kabi
  • Otsuka Pharmaceutical
  • RAUMEDIC AG
  • EA Pharma
  • Meiji
  • Arla Foods Ingredients
简介目录
Product Code: 15570

The Global Enteral Nutrition Ingredients Market was valued at USD 4.31 billion in 2025 and is estimated to grow at a CAGR of 7.3% to reach USD 8.58 billion by 2035.

Enteral Nutrition Ingredients Market - IMG1

Market expansion is supported by the rising demand for long-term nutritional support driven by the growing burden of chronic health conditions and the expanding need for clinical nutrition solutions. Healthcare providers are increasingly favoring enteral nutrition over alternative feeding approaches due to its cost efficiency, lower complication risks, and improved patient recovery outcomes. This sustained shift is directly driving demand for core nutritional ingredients, including proteins, carbohydrates, lipids, vitamins, and minerals. Demographic changes also play a critical role, as the global elderly population continues to grow and requires specialized nutritional management. Expanding geriatric care services across medical and assisted-care facilities is encouraging manufacturers to develop ingredients that are easier to digest and nutritionally optimized. In parallel, continuous innovation in ingredient processing and formulation technologies is enhancing product effectiveness, tolerance, and clinical applicability, further supporting market growth.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$4.31 Billion
Forecast Value$8.58 Billion
CAGR7.3%

The carbohydrate ingredient segment accounted for USD 1.36 billion in 2025 and is projected to register a CAGR of 6.7% from 2026 to 2035. Growth across ingredient types is being shaped by more advanced formulation requirements and evolving clinical nutrition standards. Proteins are increasingly incorporated to support muscle preservation and recovery, while carbohydrate ingredients are being refined to deliver sustained energy and improved metabolic response. Lipids and fats are increasingly formulated into specialized structures to improve absorption and digestive tolerance. This broadening of ingredient functionality is expanding their application across both standard and condition-focused nutritional formulations.

The critical care and intensive care unit application segment generated USD 1.56 billion in 2025 and held a 36.3% share, with a CAGR of 6.6% through 2035. Shifts in clinical nutrition practices are driving earlier initiation of enteral feeding in acute care environments, increasing demand for ingredients that support metabolic stability and organ function. Nutritional support is also becoming increasingly integrated into disease management pathways, raising formulation complexity and ingredient utilization.

North America Enteral Nutrition Ingredients Market accounted for USD 1.79 billion in 2025 and is expected to maintain strong growth throughout the forecast period. The region benefits from advanced healthcare infrastructure, consistent reimbursement frameworks, and widespread adoption of clinical nutrition in hospital and home-care settings. The United States plays a central role due to its aging population and high incidence of long-term health conditions, with clinical guidelines increasingly emphasizing targeted nutrition interventions using specialized proteins, lipids, fibers, and micronutrients.

Key participants in the Global Enteral Nutrition Ingredients Market include Fresenius Kabi, Abbott, Meiji, Nutricia (Danone), Nestle Health Science, and other established suppliers. Companies operating in the enteral nutrition ingredients market are strengthening their competitive position through continuous product innovation and targeted ingredient development. Many players are investing in research to enhance the bioavailability, digestibility, and clinical efficacy of core ingredients. Strategic collaborations with healthcare providers and expansion of production capabilities are helping companies meet rising demand across hospital and home-care settings. Firms are also focusing on disease-specific formulations to align with evolving clinical protocols.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Ingredient Type
    • 2.2.3 Application
  • 2.3 TAM Analysis, 2026-2035
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter’s analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By product
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and Environmental Aspects
    • 3.12.1 Sustainable Practices
    • 3.12.2 Waste Reduction Strategies
    • 3.12.3 Energy Efficiency in Production
    • 3.12.4 Eco-friendly Initiatives
  • 3.13 Carbon Footprint Considerations

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Ingredient Type, 2022- 2035 (USD Billion, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Protein Ingredients
    • 5.2.1 Whole Proteins
    • 5.2.2 Hydrolyzed Proteins/Peptides
    • 5.2.3 Free Amino Acids
    • 5.2.4 Functional Amino Acids
  • 5.3 Carbohydrate Ingredients
    • 5.3.1 Maltodextrins
    • 5.3.2 Corn Syrup Solids / Glucose
    • 5.3.3 Complex Carbohydrates
    • 5.3.4 Simple Sugars
  • 5.4 Fat / Lipid Ingredients
    • 5.4.1 Long-Chain Triglycerides (LCTs)
    • 5.4.2 Medium-Chain Triglycerides (MCTs)
    • 5.4.3 Omega-3 Fatty Acids
    • 5.4.4 Monounsaturated Fatty Acids (MUFA)
    • 5.4.5 Structured Lipids & Blended Emulsions
  • 5.5 Fiber Ingredients
    • 5.5.1 Soluble Fibers
    • 5.5.2 Insoluble Fibers
    • 5.5.3 Resistant Starch
    • 5.5.4 Prebiotic Fibers
  • 5.6 Micronutrient Ingredients
    • 5.6.1 Vitamins
    • 5.6.2 Minerals
    • 5.6.3 Electrolytes
    • 5.6.4 Trace Elements
  • 5.7 Functional & Immunonutrition Ingredients
    • 5.7.1 Nucleotides
    • 5.7.2 Probiotics
    • 5.7.3 Antioxidants
    • 5.7.4 Bioactive Peptides
  • 5.8 Others

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 (USD Billion, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Critical care / intensive care unit (ICU)
  • 6.3 Oncology / cancer
  • 6.4 Gastrointestinal diseases
  • 6.5 Neurological disorders
  • 6.6 Metabolic disorders
  • 6.7 Others

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 (USD Billion, Kilo Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East & Africa

Chapter 8 Company Profiles

  • 8.1 Abbott
  • 8.2 Nutricia (Danone)
  • 8.3 Nestle Health Science
  • 8.4 Fresenius Kabi
  • 8.5 Otsuka Pharmaceutical
  • 8.6 RAUMEDIC AG
  • 8.7 EA Pharma
  • 8.8 Meiji
  • 8.9 Arla Foods Ingredients